Publications by authors named "Lucas Gabriel Maltoni Romano"
Article Synopsis
- The study analyzed metabolic syndrome prevalence in women with polycystic ovary syndrome (PCOS) from Southeast Brazil compared to women with normal ovulatory cycles, focusing on their body mass index (BMI).
- Results showed that obese women with PCOS had a significantly higher prevalence of metabolic syndrome (67.9%) compared to controls (10.5%), with similar trends observed in other BMI categories.
- Overall, women with PCOS exhibited higher rates of all metabolic syndrome defining criteria, indicating a stronger association between PCOS and metabolic issues regardless of BMI.
Polycystic ovary syndrome (PCOS) has a heterogeneous phenotypic distribution that can potentially lead to variations in metabolic repercussions. A cross-sectional study was conducted with 372 women of reproductive age (146 of whom were ovulatory and 226 with PCOS) divided into groups according to PCOS phenotype: (i) complete phenotype involving menstrual irregularity (MI), hyperandrogenism (H), and ultrasound (US) findings of polycystic ovaries (132 patients); (ii) MI + H (18 patients); (iii) MI + US (51 patients); and (iv) H + US (25 patients). The frequencies of metabolic syndrome (MetS) were 45.
View Article and Find Full Text PDFPurpose: To compare the metabolic characteristics of obese and non-obese young women with polycystic ovary syndrome (POS) from the Brazilian Southeast.
Methods: This was a cross-sectional study conducted on 218 women of reproductive age with a diagnosis of POS--90 non-obese women (BMI between 18.5 and 29.
Leukostasis is a relatively uncommon but potentially catastrophic complication of acute myelogenous leukemia (AML). Prompt leukoreduction is considered imperative to reduce the high mortality rate in this condition. Leukapheresis, usually associated with chemotherapy, is an established approach to diminish blast cell counts.
View Article and Find Full Text PDF